hr

Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Top

Hepatoma Research is Accepted for Inclusion in Scopus

Published on: 9 Aug 2021 Viewed: 612

We are pleased to announce that the journal Hepatoma Research  (ISSN / E-ISSN: 2394-5079 / 2454-2520; Publisher: OAE Publishing Inc.) has been accepted for inclusion in Scopus by the Content Selection & Advisory Board (CSAB) after a rigorous evaluation on August 7, 2021.

We are delighted to have reached this new goal, which is a new breakthrough for journal development over the past years. We thank all our cooperated researchers who made contributions and efforts for our journal development over the past years.

Due to the COVID-19 pandemic and other factors, the Scopus onboarding process will take more than three months and the journal will be listed in Scopus in delay. The editorial office will update this process and the information.

As an academic publishing platform, we will continuously endeavor to publish more valuable and scientific research findings to promote scientific innovation.


© 2016-2021 OAE Publishing Inc., except certain content provided by third parties